MRO None - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
MRO Stock | Fundamental Analysis & Investment Insights
NYSE
N/A
N/A
Current Price
Live
$N/A
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 17, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
65%
Analysis Accuracy
The company exhibits critically weak financial health with a Piotroski F-Score of just 1/9, indicating severe deterioration in fundamental performance. Despite occasional earnings surprises, the lack of available valuation, profitability, and balance sheet metrics—combined with negative year-over-year EPS growth of -16.9%—raises substantial concerns. The absence of an Altman Z-Score prevents definitive bankruptcy risk assessment, but the extremely low Piotroski score strongly suggests operational and financial distress. With no dividend strength, weak insider sentiment, and no technical momentum, the investment profile is unattractive at this time.
Key Strengths
Occasional positive earnings surprises, particularly in early 2021 and 2019, indicating potential operational turnarounds or cost management in past cycles
Recent quarterly EPS beat in Q3 2024 (actual $0.64 vs. est $0.64) after a string of misses, suggesting possible stabilization
Historically strong earnings surprise in 2019 (up to +330%) indicating past agility or underappreciated earnings power
Insider sentiment at 40/100, though neutral, does not reflect aggressive selling typically seen in distressed firms
Most recent Q/Q EPS growth of +1.6% hints at marginal sequential improvement
Key Risks
Critically low Piotroski F-Score of 1/9 signals widespread financial weakness across profitability, leverage, and operating efficiency
Lack of Altman Z-Score prevents proper distress risk evaluation, but low Piotroski score implies high default probability
Negative YoY EPS growth of -16.9% indicates deteriorating earnings power
Absence of key financial data (revenue, margins, debt, cash flow) suggests opacity or unavailability, increasing investment risk
Declining earnings trend since 2022 peak ($1.32 in Q3 2022 to $0.64 in Q3 2024), reflecting structural or cyclical headwinds
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
21
Weak
20
35
40
10
0
AI Verdict
High-risk profile with insufficient data to support investment
Key drivers: Piotroski F-Score of 1/9, Missing financial metrics across valuation, profitability, and cash flow, Negative YoY EPS growth, No analyst target or recommendation data, Declining earnings trend since 2022
Confidence
60%
Value
20/100
Ref P/E, PEG, Graham Number
Positives
No standout positives identified.
Watchpoints
- Graham Number and Intrinsic Value unavailable
- All valuation ratios (P/E, P/B, PEG, EV/EBITDA) missing
- No current price or market cap data to assess relative value
Future
35/100
Ref Growth rates
Positives
- Q/Q EPS growth of +1.6% in latest quarter
- Earnings stabilized near $0.64 after prior volatility
Watchpoints
- YoY EPS growth at -16.9%
- Forward P/E and growth guidance unavailable
- No clear evidence of sustained recovery
Past
40/100
Ref Historical trends
Positives
- History of large earnings surprises (e.g., +330% in Q1 2019)
- Consistent beats in 2021 and 2022
Watchpoints
- Progressive decline in EPS since 2022
- Missed estimates in 2 of last 4 quarters
- High volatility in earnings performance
Health
10/100
Ref Altman Z-Score, Piotroski F-Score
Positives
No standout positives identified.
Watchpoints
- Piotroski F-Score of only 1/9 (critical weakness)
- Altman Z-Score unavailable, increasing uncertainty
- No data on debt/equity, current ratio, or cash/debt levels
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- Dividend Strength score of 0/100
- No dividend yield, payout ratio, or ex-dividend date available
- No indication of dividend history or policy
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A
Profitability
Profit margins and return metrics
Profit Margin
N/A
Operating Margin
N/A
Gross Margin
N/A
ROE
N/A
ROA
N/A
Growth
Revenue and earnings growth rates
Revenue Growth
N/A
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A
Quarterly Earnings History
EPS performance vs analyst estimates
2024-11-06
$0.64
+0.8% surprise
2024-08-07
$0.63
-9.6% surprise
2024-05-01
$0.55
+1.0% surprise
2024-02-21
$0.69
+5.2% surprise
Past News Coverage
Recent headlines mentioning MRO from our newsroom.
Newest → oldest
No matching news yet.